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Dietary Policy, Controversy and Proof: “Doing Something”
versus Waiting for the “Definitive Evidence”

Controversies over diet and its relationship to health are never out of the headlines for long. At the
beginning of the 21st century, a heated debate is in progress about the causes of the obesity epidemic
sweeping the United States and some other nations (1, 2). The percentage of the population classified
as obese in the US jumped from 14.5 % in 1971 to 30.9% in 2000 (3). Many commentators attribute
the increase to simple overeating. In their view, Americans, spurred on by advertising and everincreasing serving sizes, are ignoring dietary advice and consuming more calories than they are
expending (1, 2, 4). Others maintain that the problem is more complex. A few researchers claim that
recent dietary advice (5, 6), which advocates restricting fats and increasing carbohydrate intake, is
contributing to weight gain. According to them, dieters following stricter versions of this regime are
upsetting the insulin-based physiological system that regulates blood sugar, appetite and fat
metabolism, with the result that they gain weight and often develop diabetes (1, 2). Alongside this
recent skepticism about the wisdom of fat avoidance is a renewed interest on the part of mainstream
medicine in the controversial Atkins diet – a high fat, low carbohydrate regime that was for decades
relegated to the realm of quackery. Baffled and frustrated by obese but starving patients who fail to
lose weight, some orthodox physicians have begun testing Atkins’ claims (7, 8) much to the chagrin of
those who find any questioning of the anti-fat message a danger to health (9).

As these recent controversies illustrate, discussions about diet, disease and health take place in a highly
politicized arena. In an ideal world, scientific research would settle controversies, as the opposing
parties would be forced to agree on hard and indisputable facts. However, within the vast body of
knowledge related to diet and disease, there are many contradictory claims and experimental results
that are open to conflicting interpretations. Nonetheless, because of intense public, commercial and
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political interest, health policy makers are under considerable pressure to come up with answers and
advice. Although policy decisions draw on and lend legitimacy to some interpretations of the
“evidence”, other interpretations are often possible, and controversies erupt again. This chapter traces
the development of one view of the healthy diet – a diet that is low in fats, and high in carbohydrates.
Although it became mainstream and widely accepted during the second half of the 20th century, this diet
was the subject of considerable controversy. It was primarily developed and promoted as a response to
a disease that was rife in the decades after World War II – coronary heart disease (CHD). The rise of
the low fat diet is therefore closely bound up with attempts to “do something” about CHD at a
population-wide level.

The chapter covers the period from the 1940s, when medical and lay awareness of the increasing
incidence of CHD began to grow, to 1985, the year the National Cholesterol Education Program
(NCEP) began its widespread and concerted effort to sell the anti-fat, anti-cholesterol message to the
nation. This campaign marked a victory for advocates of fat reduction over skeptics who, for decades,
continued to question the efficacy of low fat diets as a means of preventing disease. To make sense of
the scientific knowledge, its policy ramifications, and the controversy as a whole, it is useful to divide
the knowledge linking fats, cholesterol and heart disease into three separate but related hypotheses.
These are (1) that higher serum cholesterol levels are associated in some way with an increased risk of
CHD, (2) that serum cholesterol levels can be reduced by modifying the fat and cholesterol content of
the diet, and (3) that a cholesterol-lowering diet will reduce the risk of developing cardiovascular
disease. By the mid-1960s, scientists had established the validity of hypotheses 1 and 2. However,
hypothesis 3 remained problematic. While scientists struggled to test its validity, public, commercial
and political interest in the link between diet and disease intensified, stimulating the creation of policy
before the issue was resolved to everyone’s satisfaction. The history of dietary policy in post-war
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America provides a fascinating insight into the way science, culture, economics and politics intertwine
with policy-making in the field of public health.

Putting Cardiovascular Diseases on the Public Health & Medical Research Agenda

Although rates of CHD in the US increased markedly during the first half of the 20th century (10, see
also the accompanying chapter), there was initially little public awareness of the disease. Lay people
and medical organizations were still primarily interested in treating and preventing infectious diseases.
In 1945, for example, a report on fund-raising by voluntary health agencies stated that the funds raised
that year represented $94 for each case of infantile paralysis, $22 for each case of tuberculosis, $8 for
cancer, and 3 cents for each case of heart disease (11). Over the next 10 years, a group of cardiologists
and medical research lobbyists worked diligently to raise the profile of cardiovascular diseases (CVD),
or diseases of the circulation. Their efforts were closely bound with another highly successful
campaign, led by wealthy philanthropists Mary and Albert Lasker, to increase funding for research into
chronic diseases in general. The Laskers and their allies fervently believed that well funded research
would soon produce cures for CVD and cancer. In 1948, the Federal government rewarded their efforts
by establishing the National Heart Institute (NHI) (12-14). Funds for research rose steadily. Between
1950 and 1967, annual funding escalated from $16 million to $164 million (14).

The American Heart Association (AHA) was also involved in these efforts. In 1946 the Association,
until then a private, professional body, voted in favor of becoming a national voluntary health agency,
which allowed it to expand its public education and fund-raising activities (15). It established a
National Heart Week, and used newspapers, radio, magazines, Hollywood stars and community
organizations to publicize heart disease and the need for more money for research. It distributed heartshaped collection boxes to drugstores emblazoned with the slogan “Open Your Heart...Give to Fight
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the Heart Diseases, America's Number One Killer” (16, 17). The 1949 campaign raised $2,850,000,
and the 1950 campaign raised a further $4 million (18, 19). The Association estimated that during its
first 12 years as a voluntary health agency, it channeled nearly $50 million into research (20).

Before 1950, scientific knowledge about the causes of CVD was indeed scanty. Early experiments with
rabbits suggested some kind of link between diet and atherosclerosis. However, many scientists
believed that these findings could not be extrapolated to humans (21, 22). During the 1930s and 1940s,
scientists found higher levels of serum cholesterol in humans with various diseases of the kidneys and
circulation (23, 24). Hints also began to emerge that serum cholesterol levels could be decreased by
manipulating the diet. In the late 1940s patients with high blood pressure were often treated with a very
strict rice-fruit diet, which contained no cholesterol and virtually no fat. Researchers observed that
patients on this diet experienced substantial decreases in serum cholesterol levels (25, 26). They
conducted experiments to investigate the comparative effects of vegetable and animal fats on serum
cholesterol. However, results were confusing and contradictory (27, 28). They would remain so until
the second half of the 1950s, when scientists redefined the problem in terms of fat saturation.

Early publicity reflected the uncertainty about the causes of cardiovascular diseases. In 1947, Better
Homes and Gardens published an article titled “The 100% American Way to Die”, which informed
readers of the growing incidence of several forms of cardiovascular disease, including coronary
thrombosis, stroke, hypertension and rheumatic heart disease (29). It canvassed several theories of
causation, including “high-cholesterol foods”. The section on cholesterol ended with a caution: “It’s
only a theory yet, nothing that should justify tampering with a good diet unless your doctor himself
tells you to” [emphasis in original]. Instead, the advice given was vague and general, and based on an
assumption that cardiovascular diseases were caused by some mixture of stress, overeating and lack of
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exercise: - “calm down and get out into the sun” readers were advised, “instead of rushing and
worrying and getting flabby and stuffing your paunch with the $3 dinner” (29).

Early Heart Disease Epidemiology – Ancel Keys & The Framingham Heart Study

Of the many projects funded during the medical research boom of the 1950s, only a few stand out as
having played pivotal roles in the development of knowledge about CHD and its causes. In 1951
Ancel Keys met a fellow physiologist from Naples who told him that the disease was not a problem
in his home city. This stimulated Keys to set up a comparative study of the heart disease rates and
diets of various socio-economic groups in Naples, Madrid and Minnesota. He found very little heart
disease among the poorer populations of Naples and Madrid and attributed this to their diets, which
contained little meat and few dairy products (27). Keys presented these findings at two international
congresses in 1952. In a memoir published in 1990, he wrote that the findings “were politely
received but few were convinced that diet had anything to do with coronary heart disease” (30). At
the time, dietary policies aimed to prevent deficiencies, not to deter excess. As milk, meat and eggs
supplied protein, iron and valuable vitamins, they were considered healthy – not potentially
pathogenic (31).

The large gap between Keys’ ideas and those of the majority of his colleagues is evident in a
symposium on atherosclerosis published in the AHA journal Circulation in 1952 (32). In the
symposium, Louis Katz, an eminent atherosclerosis researcher, said that he would only prescribe a lowfat, low-cholesterol diet for obese patients or for those who had already had two or more heart attacks
because: “prohibitions should not be carelessly advocated until such time as it is clearly revealed that
the prohibition has a great chance of being beneficial to the patient” (32). Keys, on the other hand,
boldly asserted that “if mankind stopped eating eggs, dairy products, meats and all visible fats”,
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atherosclerosis would become “very rare”. His diet for atheroschlerosis patients included skim milk,
lean meat or fish and “a boiled or poached whole egg for Sunday” (32). It would be at least another
decade or two before other doctors would consider such a strict diet to be appropriate for heart disease
patients.

In contrast to his later seven countries study (33), Keys’ early investigations were retrospective – that
is, they compared variables at a single point in time, seeking to correlate possible causes with disease
after the disease had manifested itself. Critics found it easy to question these studies because there was
no guarantee that the putatively causal variables (for example, high fat diet, high cholesterol levels)
chronologically preceded the putative outcome (CHD). To overcome these problems, epidemiologists
devised prospective studies. In these, they chose persons, randomly or otherwise, and characterized
them according to various criteria. A research team then periodically investigated the incidence of new
disease among subjects, and determined causes of death in those who died between examinations.
Epidemiologists argue that these studies are more rigorous because the characteristics of the persons
under observation are measured before the disease appears.

In post-war America, epidemiologists set up many prospective studies (34-39). The most famous and
influential was – and is - the Framingham Heart Study. Begun in 1947, it was taken over by the newly
formed NHI in 1949. The original aim was to study the incidence of heart disease over time in a
defined community - the town of Framingham, about 20 miles from Boston. However, the new NHI
directors decided that it could also be used to search for “constitutional and conditioning factors” (later
known as “risk factors”) associated with the development of the disease. Accordingly, they expanded
the range of personal and medical information to be collected (40). The original cohort consisted of
2,282 men and 2,846 women aged 30-59 years; all were subjected to a thorough medical examination
and questioning, then recalled every two years for re-examination. Causes of death were sought for
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those who died between examinations (41). In 2004, the study was still collecting data on the
remaining members of the original cohort, as well as their spouses and offspring.

Data from the first four years of the Framingham study did not appear until 1957 (42), and the risk
factors that are now so well known did not become clear until the early 1960s. In the meantime, there
was a great deal more publicity about CHD and its causes, much of it fuelled by the work of Ancel
Keys.

More Publicity and the First Battles over Policy

In the mid-1950s some sectors of the popular press became much less circumspect in their reports
about the links between diet and heart disease. A 1954 Newsweek article reporting on a recent
conference was titled “Fat's the Villain”. Much of the article was taken up with descriptions of the
retrospective country comparisons made by Keys and his colleagues. The author summarized the work
with the claim: “A world survey of recently discovered facts shows that cardiovascular troubles are
most common in countries where there is the most fat in the diet” (43). In December 1955 the Reader's
Digest also published a flattering article describing Keys' research, and cautiously advocated dietary
change (44). The news-worthiness of CHD received a further boost in September 1955 when President
Eisenhower suffered a heart attack (45).

While publicity about heart disease and its possible links to fat consumption increased, the question of
the effects of different types of fats on serum cholesterol levels remained unresolved. This issue was of
great interest to sectors of the food industry, some of which were linked to scientific research through
the Nutrition Foundation, an industry-funded research body (46). In exchange for a membership fee,
companies gained access to the latest knowledge about nutrition. Although the direction of research
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was decided by a Scientific Advisory Committee, it was open to influence by industry representatives.
During the 1950s, member companies offered to donate an extra million dollars over and above their
usual payments if the Foundation would fund an intensive research effort into the effects of different
types of fats on serum cholesterol (46). The Committee agreed. It was during this time that scientists
managed to sort out the confusion by reframing the problem as one of fat saturation. The findings were
consistent and non-controversial. Despite some variation among persons, the lowest cholesterol levels
were obtained by ingesting oils with high concentrations of polyunsaturated fatty acids (47). Soon after
these studies were published, the first polyunsaturated margarine appeared, and vegetable oil
manufacturers began to claim that their products could prevent heart disease (48, 49).

The new findings quickly found their way into the popular press and stimulated another spate of
articles on diet, cholesterol and heart disease. By this time, Keys was no longer alone in advocating
dietary change. In 1956 Time published this bold claim by New York nutritionist Norman Jolliffe: “No
prudent person who has had, or wishes to avoid, coronary heart disease should eat a high-fat diet of the
type consumed by most Americans.... Stress and strain, physical indolence, obesity, luxury living or
tobacco play but a minor role” (50). Jolliffe and colleagues persuaded more than 1,000 men in New
York to join an “Anti-Coronary Club” in which they would abide by his dietary rules (51). He hoped
that within five years he would have enough data to prove the salutary effects of diets low in saturated
fats (50).

The public advocacy of low-fat diets troubled some of the more conservative members of the scientific
profession. In May 1957, two researchers went public with a message of caution published in a
Newsweek cover story titled “The Diet Mania - Do Fats Really Kill?”. The article began: “Currently the
dieters are swarming to a new fad - the anti-cholesterol or low-fat diet - though scientists have not yet
reached any considerable measure of agreement as to whether such a diet does anything but harm”
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(52). The author asserted that cholesterol was “the mysterious compound around which one of
medicine's most heated controversies is now raging” and contrasted the views of Keys and Jolliffe with
those of Frederick Stare (a Harvard University nutritionist), and Irvine Page (a former president of the
AHA). Page was particularly critical of Keys' country comparison studies. Foreign CHD statistics were
unreliable, he said, because of “poor methods of reporting, understaffed health departments, and
dubious autopsy proceedings”. He claimed that there was not yet enough evidence to justify “wholesale
tinkering with the American diet” (52).

Page and Stare were also the leading authors of the first AHA policy statement on diet and heart
disease, published in Circulation in August 1957. Although some later accounts cite this report as the
first policy statement advocating reductions in dietary saturated fat (e.g. 5), it was actually quite
cautious and circumspect. The five authors expressed concern about a “flood of diet fads and
quackery” (53). They noted that, “great pressure is being put on physicians to do something about the
reported increased death rate from heart attacks in relatively young people”. However, they warned,
“some scientists have taken uncompromising stands based on evidence that does not stand up under
critical examination” (53). They expressed skepticism about Keys' studies, and warned against the
extrapolation of results from formula dietary experiments to the general population. They argued that
there was not enough evidence to “permit a rigid stand” on the link between diet and heart disease and
concluded: “We are certain of one thing: the evidence now in existence justifies the most thorough
investigation” (53).

Several leading scientific and medical organizations supported the conservative stance of the AHA,
including the Research Council of the National Academy of Sciences (54), the AMA Council on Foods
and Nutrition (55) and the Nutrition Foundation (49). In December 1959, the FDA issued a statement
announcing that “the role of cholesterol in heart and artery diseases has not been established. A causal
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relationship between blood cholesterol levels and these diseases has not been proved”. Therefore,
advertising claims linking consumption of vegetable oils and margarine to a decreased risk of heart
disease were “false and misleading” (56).

Changes in Policy

The late 1950s and early 1960s were pivotal years in the history of dietary policy. While the AHA and
other organizations initially advised caution, Mary Lasker, the wealthy philanthropist and influential
advocate of medical research, tried to persuade doctors to “do something” about cardiovascular disease,
even in the face of imperfect knowledge (12) . A decade had passed since her lobbying efforts had
helped establish the NHI, and she and her allies now turned their efforts to public education. In 1959,
she persuaded eight physicians, including five former AHA presidents (erstwhile conservatives Page
and Stare among them), to issue a statement under the auspices of the National Health Education
Committee - a Committee which she chaired. The statement outlined five “factors predisposing to
arteriosclerosis” – “heredity, overweight, elevated blood cholesterol level, elevated blood pressure and
excessive cigarette smoking”. People were advised to see their doctors if any of these factors were
present (57).

By now, generous funding for research was yielding results, and some aspects of the links among diet,
cholesterol levels and CHD were becoming clearer. In 1960, Time magazine reported that at the AHA’s
annual meeting, the “great cholesterol controversy” was beginning to subside, and that “even onetime
skeptics were prepared to concede that abnormal quantities of fatty material in the blood should be
regarded as one of the major factors in producing heart-artery disease” (58). Shortly after this, the
AHA released another policy statement (59). This time, it cautiously endorsed dietary change. The
statement was formulated by an elite group of six scientists, including Page and Stare. However, the
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group now had two new members - Keys and another staunch supporter of dietary change, Jeremiah
Stamler. The document began by announcing: “Current available knowledge is sufficient to warrant a
general statement regarding the relation of diet to the possible prevention of atherosclerosis” (59). As
supporting evidence it cited Keys’ work, about which no doubts were raised, and animal and human
dietary experiments. The AHA worded its recommendations carefully: “These and other research
studies have given clues as to the prevention of atherosclerosis by dietary means. A reduction in blood
cholesterol by dietary means, which also emphasizes weight control, may lessen the development or
extension of atherosclerosis and hence the risk of heart attack or strokes. It must be emphasized that
there is as yet no final proof that heart disease or strokes will be prevented by such measures” (59).
The policy statement recommended dietary changes for overweight people, those who had already had
a heart attack or stroke, men with a family history of heart disease, high cholesterol, high blood
pressure and for those “who lead sedentary lives of relentless frustration” (59).

The AHA statement listed 23 references in support of its recommendations. Most described
experiments in which cholesterol levels were reduced by modifying the diet. Others were
epidemiologic studies linking high cholesterol levels or other variables with an increased risk of heart
disease. In other words, the studies were concerned with the first two of the three hypotheses outlined
above. Only two of the references discussed experiments designed to test the crucial final link in the
chain - whether dietary change (through a reduction of cholesterol levels) could also reduce the
incidence of cardiovascular disease. These studies were Jolliffe's Anti-Coronary Club (60) and an
English study with people who already had CHD (61). Both papers described how the studies were set
up, but were too recent to yield any data.

The Search for the Definitive Evidence
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Before, during and after the AHA’s first cautious endorsement of dietary change, scientists continued
to work towards the “definitive proof”. Ideally, this would be an experiment demonstrating a reduction
in the incidence of heart disease in people consuming a cholesterol-lowering diet. Some early studies
were suggestive. In 1950 and 1951, John Gofman and colleagues published reports claiming that diet
could reduce the incidence of further attacks in heart disease patients (62, 63). Lester Morrison, a
doctor from Los Angeles, made similar claims on the basis of a twelve year study of 100 patients (64).
However, neither study held up well under later standards of methodology and reporting, and were not
cited in the AHA’s 1961 policy statement.

The 1950s and 1960s were decades of rapid change in the design of clinical trails (65). What passed for
a reasonable experiment in the 1950s was deemed to be full of errors by the end of the 1960s. For
example, Jolliffe’s Anti-Coronary Club recruited subjects with a previous history of heart disease,
obesity, hypertension or diabetes alongside those who were healthy. No thought was given to the
establishment of a control group. The investigators tried to improve their study later by adding a
retrospective control group, and excluding men with a previous history of heart disease from the
analysis. Results published in 1966 claimed that men who lowered their fat intake suffered less heart
disease (51). However, because of its flaws, the study did not qualify as the “definitive proof”. The
same was true of other early studies (66).

During the 1960s, scientists did strive to set up a large, well-designed study that would finally settle the
issue. In 1960 the NHI began funding a National Diet-Heart Study that involved many prominent
researchers. Their aim was to investigate the effects of dietary change on normal, healthy men.
However, they calculated that, for such an experiment to yield a statistically significant result, they
would need to enroll 100,000 subjects for five years (67) – a formidable task, but one that the scientists
were determined to carry out. Because of the expense and sheer logistical difficulties, they spent
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several years conducting feasibility studies. Their report, published in 1968, claimed that the
experiment was feasible, and recommended that the NHI carry it out as soon as possible (68).

However, a few years later, an NHI task force recommended against a purely dietary study. Instead, it
called for a “multiple risk factor intervention trial” (MRFIT), designed to test whether a combined
attack on smoking, high blood pressure and cholesterol levels would prevent deaths from CHD (69).
Investigators began planning this experiment in 1971, and the results were published in 1982 (70).
Scientists thus spent more than two decades designing and conducting a large trial of the cholesterol
hypothesis. In the meantime, those concerned with promoting health found it difficult to wait. Instead,
public, political and commercial interest in the links between diet and disease mounted. More policies
were formulated. By the time MRFIT produced a result, the urgency had passed.

The 1960s: More Controversy and More Policies

There is a fine line between scientifically respectable treatment and so-called faddism – the use of
unproven remedies and preventative measures. Such practices are beyond doctors’ control (71), and
orthodox medical organizations often warn against the use of “fad” diets – that is, diets outside the
realm of official recommendations – for weight loss and/or health reasons (72, 73). Without definitive
evidence of their efficacy, cholesterol-lowering diets in the early 1960s hovered on the edge of
“faddism”. However, mounting suggestions of a positive correlation between high cholesterol levels
and disease, and the possibility of lowering levels through diet, gradually made cholesterol-lowering
diets a scientifically respectable, if still experimental, treatment for patients at high risk of heart
disease.
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The AHA’s cautious endorsement in 1960 of cholesterol-lowering diets for high risk patients may have
been an attempt to regain control over knowledge linking diet to cardiovascular diseases (74, 75).
Ironically, however, its equivocal tone encouraged the opposite effect. Its cautious endorsements and
careful provisos were exploitable by both sides of the controversy. Vegetable oil companies tested the
limits of the FDA ban on health claims by highlighting the AHA statement in advertisements. The
National Dairy Council, on the other hand, seized on the disclaimer about “no final proof” to support
its counter-claim that “The idea that replacing some ‘saturated’ fats with ‘unsaturated’ fats will help
prevent heart disease is clearly unproved” (76).

In 1962, the AMA Council on Foods and Nutrition published a statement on “The Regulation of
Dietary Fat” that, like the AHA report, cautiously endorsed dietary change for those at increased risk of
heart disease (77). It received wide coverage in the popular press (74,75). The Council was so
disturbed by the enthusiastic media and lay response that it issued a press release titled “Latest Food
Fad is Wasted Effort”, that tried, once again, to regain control. It pointed out that laboratory tests were
necessary to determine cholesterol levels, and stressed that doctors should be in charge of any dietary
change (78, 79). Again, vegetable oil companies and the dairy industry exploited the situation. Another
round of claims and counter-claims created even more confusion (80-82).

During the 1960s, the lobbyists whose efforts had initially helped to stimulate the massive research
effort into the causes of cardiovascular disease became increasingly impatient with the scientists’
equivocation. Mary Lasker and her allies used their influence in Congress and the NIH to push for
comprehensive policies aimed at “conquering” heart disease. When these failed to materialise, they
asked President Kennedy to establish a “President’s Conference on Heart Disease and Cancer” (83).
Kennedy was assassinated before these efforts bore fruit. However, President Johnson, a sufferer of
CHD and personal friend of Lasker’s, was a staunch ally of the health lobbyists. His Commission on
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Heart Disease, Cancer and Stroke was the second such commission established during his
administration, after the Commission on the Assassination of President Kennedy (84). In 1964, it
produced a report recommending the establishment of new regional centers for research and treatment
of cancer and heart disease, extra training for physicians and education for the public (85). The AMA
opposed the effort, known as the Regional Medical Program, because it smacked of state intervention
in medical practice (86). The recommendations were watered down. Nevertheless, one outcome of the
Program did affect policy. An Inter-Society Commission on Heart Disease Resources brought together
representatives from 29 medical organizations to formulate policies on prevention, diagnosis, treatment
and rehabilitation (87).

All these activities – the articles in the popular press, the conflicting advertisements, the lobbying, and
the Commission - were indications of mounting interest in the relationship between diet and heart
disease. The demands that something be done created problems for scientists, as developments in
clinical trial methodology made it increasingly difficult for them to produce quick answers.
Nevertheless, while the definitive proof of the efficacy of cholesterol-lowering remained elusive,
investigations of other aspects of the links between cholesterol and CHD continued. During the 1960s,
more epidemiologic studies were reported, including several from Framingham (88-90). The studies
affirmed a consistent positive correlation between serum cholesterol levels and risk of cardiovascular
diseases.

In the mid-1960s, the AHA and the AMA decided to broaden their dietary recommendations to include
people who did not already have heart disease (91, 92). Both statements cited new epidemiologic
knowledge to justify the move to primary prevention. The AMA Council stated: “The observations
regarding risk which support this position are derived chiefly from the Public Health Service Study in
Framingham, Mass.” However, it also noted: “it must be recalled that definitive proof that lowering
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serum cholesterol, or preventing a rise in serum cholesterol, will lower the morbidity and mortality
associated with coronary heart disease, is still lacking” (91). Over the next decade, researchers
continued to refine and expand their understanding of many aspects of CHD. Several more policy
statements advising dietary change were published (66, 93). For a time, it seemed as though the
cholesterol controversy had died down. It re-ignited, however, when the Federal Government reentered the dietary policy arena in the 1970s.

Government Involvement in Nutrition Policy

Since 1917, when it issued its first set of dietary guidelines, the Department of Agriculture (USDA) has
been the federal agency responsible for formulating and disseminating nutrition policies in the United
States. For most of the century, the policies were aimed at preventing deficiencies, not deterring
excess. Consumers were advised to choose foods from “protective” groups - dairy products, meat and
eggs, fruits and vegetables and so on. The first four editions of the USDA dietary guidelines, published
between 1917 and 1946, recommended daily consumption of up to eight food groups, including fat.
Such advice benefited the agriculture and food industries (31). However, the new scientific knowledge
linking fats and cholesterol to disease upset the comfortable relationship between food producers and
nutrition policy-makers. The USDA avoided provoking the wrath of industries selling foods containing
saturated fats and cholesterol through two decades of controversy. The 1958 edition of the dietary
guidelines did not mention fat at all, and the Department refrained from publishing any more
guidelines until 1980. The first United States government guidelines recommending reductions in fat
and cholesterol intakes were highly controversial. They did not emerge from the USDA, but from a
temporary body - the Senate Select Committee on Nutrition and Human Needs (SCN) (31).

18
The SCN was initially established in 1968 to tackle malnutrition due to poverty. In 1976, it turned its
attention to what it called “Diet Related to Killer Diseases” and held hearings to “consider the role of
diet in preventive health care and the degree to which diet contributes to the development of major
diseases including heart disease, cancer and diabetes” (96-98). A few months later, the SCN released
the first edition of Dietary Goals for the United States. Among the recommendations were some very
provocative suggestions, including, “Decrease consumption of meat…Decrease consumption of
butterfat, eggs and other high cholesterol sources” (99).

The meat, diary and egg industries had made some sporadic, but unsuccessful, attempts during the
1970s to challenge claims that their products caused disease (100, 101, 97). Now, the alarm bells really
rang. If Dietary Goals were adopted as official government policy, there could be changes to nutrition
education, labeling and advertising laws, and the content of diets fed to millions of people, including
school children, hospital patients, prisoners and armed services personnel. Income price support
mechanisms might also be affected. Food industry lobbyists exerted pressure in Washington, and SCN
hearings on the Dietary Goals were re-opened. Sessions were set aside to hear testimony from the meat
and egg industries (102, 103).

Food industry lobbyists were able to accumulate numerous scientific statements expressing skepticism
about the efficacy of dietary change (104). The SCN revised the Dietary Goals and released a second
edition in December 1977. Although some proponents of dietary change claimed that industry had
exerted strong and illegitimate control over policy (95, 101), the changes were minor. The
recommended daily allowances of fats and cholesterol were unchanged. Suggestions for food selection
were reworded as follows: “Decrease consumption of animal fat, and choose meats, poultry and fish
which will reduce saturated fat intake… Decrease consumption of butterfat, eggs and other high
cholesterol sources. Some consideration should be given to easing the cholesterol goal for pre-
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menopausal women, young children and the elderly in order to obtain the nutritional benefits of eggs in
the diet “ (105).

Select Committees can act only in an investigative and advisory capacity and are not empowered to
present legislation to congress (98). In order for Dietary Goals to affect government activities, it had to
be taken up and used. Between 1977 and 1980 the situation was quite confused, as it was unclear
which sector(s) of the federal health or agricultural bureaucracy, if any, would take responsibility for
implementing policies aimed at reducing fat and cholesterol intake. For a time, there was a “turf war”
between the USDA and the Department of Health, Education and Welfare (DHEW) over nutrition
research and policy. Some food activists and their political allies expected the DHEW to take a more
proactive role in the dietary prevention of disease. However, scientists at the National Heart Lung and
Blood Institute (NHLBI), as the NHI was now called, were in a bind. They were still engaged in two
long–term and expensive experiments designed to provide the long awaited definitive proof of the
efficacy of lowering cholesterol levels. The results of MRFIT and a drug trial – the Lipid Research
Centers Coronary Primary Prevention Trial (LRC-CPPT) – would not be available until the early
1980s. Speaking out in favor of dietary change before then would be tantamount to anticipating the
results of the trials (97, 106-108).

Although the NHLBI scientists were reluctant to speak out, three sets of dietary recommendations did
emerge from various other corners of the federal bureaucracy during 1979 and 1980 – a Surgeon
General's Report titled Healthy People (109), a joint USDA-DHEW document, Dietary Guidelines for
Americans (110), and a report from the Food and Nutrition Board (FNB)of the National Academy of
Sciences called Towards Healthful Diets (111). The first two of these advocated reductions in fat and
cholesterol intakes, though the former used more emphatic language. The controversy that erupted
around the documents followed a pattern that was, by now, quite familiar. Food activists praised
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Healthy People and blamed the meat industry for the more cautious wording of the Dietary Guidelines
(108). Meat industry representatives, on the other hand, repeated their claims that the link between diet
and disease was still unproven (112).

Of the three statements, the FNB’s Towards Healthful Diets caused the most uproar. The Board had
long taken a conservative position on the cholesterol issue (54, 113). Now, members expressed concern
about what they saw as an excessive and unrealistic hope that nutrition could prevent diseases such as
cancer and heart disease, which they believed were not primarily nutritional in nature. The Board took
a skeptical approach to the evidence linking saturated fats and cholesterol to heart disease, stating that
“intervention trials in which diet modification was employed to alter the incidence of coronary artery
disease and mortality in middle-aged men have generally been negative”. It also claimed that
“epidemiology establishes coincidence, but not cause and effect” (111).

By 1980, at least 18 organizations in the US and elsewhere had formulated policies recommending
dietary change (114). The FNB was a very prestigious body, and its deviation from the prevailing
viewpoint provoked much media interest (74, 75). The debate illustrated the degree to which diet had
become a political issue (114–116). Consuming less fat and cholesterol had become a “progressive”,
pro-health, pro-consumer cause, a means through which people could protest against corporate greed.
On the other hand, political conservatives praised the FNB for taking a stance against the “Naderites”
who “mope around Washington DC proclaiming that everything we eat is unsafe” (117). However,
although the conservatives were gathering momentum (the Reagan administration was about to begin),
they were unable to gain the high moral ground on the cholesterol issue. Food activists pointed out that
some of the FNB scientists had links to the egg, dairy, meat and processed food industries (114, 118).
The FNB’s consumer liaison panel resigned in protest, and members of the Board were required to
justify their views in hearings before a House Agriculture Subcommittee (116, 119). After the FNB
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report, it was difficult for scientists to question the status of evidence in favor of cholesterol-lowering
without being labeled dupes of those sectors of the food industry that profited from the sale of saturated
fats and cholesterol..

The Large Trials and an End to Controversy

In 1982, the results of the Multiple Risk Factor Intervention Trial (MRFIT) were published (70).
Researchers had designed this trial to test the combined effects of diet, blood pressure medication, and
smoking cessation in middle-aged men exhibiting multiple risk factors for heart disease. After
screening, 12,866 men were enrolled for an average of seven years. Despite careful planning, the
results were not what the investigators had expected (70). There was no statistically significant
difference between the control and intervention groups in the primary end-point – death from CHD. In
designing the trial, scientists had used Framingham data to predict a death rate of 29 per 1,000 men in
the untreated group and 21.3 per 1,000 in the intervention group. However, the death rates were 19.3
and 17.9 respectively. The investigators gave several explanations. There were more deaths than
expected among men taking blood pressure medication. Death rates from CHD across the nation had
fallen, for reasons that were not clear. Finally, men in the intervention group had not changed their risk
factors as much as expected, while many in the “untreated” group had made changes (70). A report in
the New York Times, based on interviews with men assigned to the control group, gives an insight into
factors that affected the results. One of the men stated: “I said to myself I'm not going to be a part of
the control group and kill myself for the sake of their statistics… Once I realized that I had two risk
factors, I made some modification “(120). Despite all the careful preparation, definitive proof of the
effects of cholesterol-lowering on the incidence of coronary disease remained elusive.
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The results of the other large NHLBI test of the cholesterol hypothesis were published in 1984 (121) .
The Lipid Research Clinics Coronary Primary Prevention Trial (LRC-CPPT) was a drug trial, which
enrolled 3,806 middle-aged men in the top 5% of the risk profile for heart disease. After an average of
7.4 years of medication or placebo there was slightly less heart disease in the treated group. This result
was statistically significant, provided a one-sided test for significance was used (121). This type of test
assumes that the result of the experiment can only go one way – that is, that the treatment can only be
beneficial. It is customary to use a two-sided test in clinical trials, thus allowing for the possibility that
treatment may be harmful (122).

Although the LRC-CPPT produced a marginal result, despite enrolling only middle-aged men at very
high risk, the NHLBI claimed that it provided the long-awaited definitive proof of the efficacy of
cholesterol-lowering drugs and diets in preventing CHD in the general population (123). There was a
lively debate over the interpretation of the results in the medical journals (122, 124-126). In addition to
the unorthodox use of the one-tailed test, scientists questioned the validity of extrapolating the results
to dietary recommendations for the whole population. The deaths of men in the treatment group also
provoked concern. More men taking the drug had died from accidents, suicide and violence than in the
control group. According to some commentators, this warranted further investigation (122, 124-126).

The controversy in medical circles did not spill into the public arena. In the popular press, any lingering
uncertainty had been clarified. Time magazine, for example, featured a cover story titled “Sorry, It's
True. Cholesterol really is a Killer”. It quoted leading NHLBI investigator Basil Rifkind: “It is now
indisputable that lowering cholesterol with diet and drugs can actually cut the risk of developing heart
disease and having a heart attack” (123). Not long after the LRC-CPPT results were published,
scientists at the NIH organized a Consensus Conference on Lowering Blood Cholesterol to Prevent
Heart Disease. Despite a few dissenting voices, the conference attendees produced a strong statement in
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favor of dietary change for everyone in the US over the age of two years (127, for objections see 128,
129). It also recommended the establishment of a National Cholesterol Education Program, to convince
everyone in the US of the importance of monitoring their cholesterol levels, and if deemed appropriate,
reducing them through diet or drug treatment (130).

Conclusion

By the end of the 20th century, the anti-fat, anti-cholesterol message was widespread and wellentrenched (5,6). From time to time, dissenters have argued that the evidence in favor of dietary change
is less substantial than is commonly supposed (129, 131, 132). However, so far these arguments have
had little or no effect on policy. The institutional mechanisms in favor of fat and cholesterol restriction
have become large and well-developed. Only time will tell if, and when, and how, policy will change.
As CHD rates decline and the incidence of obesity increases, we may see a fundamental reassessment
of what constitutes healthy eating, similar to that which occurred when medical attention shifted in the
mid 20th century away from infectious diseases and vitamin deficiencies towards cancer and CHD. On
the other hand, the rise in obesity may merely provoke policymakers into intensifying their anti-fat
message.

The story of the controversies over fat, cholesterol and CHD does not hold any easy lessons for
the policymakers of the future. It provides, at best, a cautionary tale that illustrates the degree to
which policies in the field of public health are inextricably bound up with cultural, political and
economic concerns. The recent trend towards evidence-based medicine seeks to deflect pressures
and influence from these quarters by strengthening the link between policy and reliable scientific
evidence (133). However, it is unlikely that such efforts will be able to neutralize these pressures
altogether. “Evidence” is often a slippery concept, and hard to come by, and lay people,
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politicians and others will continue to demand that scientists and policy makers “do something”
about health problems in the community. Given the pressures, and the difficulties of obtaining
definitive evidence, complex political imbroglios are bound to develop. There is no way to
insulate medical science from the rest of society. The conduct and interpretation of experiments
occurs within a social context, and policy-making is inevitably a political process.

25
REFERENCES
1.

Taubes, G. What if it’s all been a big fat lie? New York Times Magazine, July 7. 2002

2.

Larkin, M. Little agreement about how to slim down the USA. The Lancet 2002;360 (2
November ): 1400.

3.

Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US
adults, 1999—2000. JAMA 2002:288:1723-7

4.

F.D.A. Obesity Working Party. Report on Obesity. 2004
http://www.fda.gov/oc/initiatives/obesity

5.

AHA Nutrition Committee. Dietary Guidelines for Healthy American Adults. Circulation 1996;
94:1795-1800 CF

6.

U.S. Department of Agriculture, U.S. Department of Health and Human Services. Nutrition and
your health. Dietary guidelines for Americans. 2000, 5th edition. Home and Garden Bulletin No.
232. http://www.usda.gov.cnpp/dietary-guidelines.html

7.

Westman EC, Yancy WS, Edman JS, Tomlin KF, Perkins CE. Effect of 6-month adherence to a
very low carbohydrate diet program. American Journal of Medicine 2002; 113(1):30-6

8.

Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, Szapary PO, Rader DJ,
Edman JS, Klein S. A randomized trial of a low-carbohydrate diet for obesity.New England
Journal of Medicine 2003; 348: 2082-2090

9.

Liebman B. The truth about the Atkins Diet, Nutrition Action 2002; 29: 1-7.

10.

Braunwald E. Shattuck Lecture: Cardiovascular medicine at the turn of the millennium: triumphs,
concerns and opportunities. New England Journal of Medicine 1997; 337:1360-9.

26
11.

Anonymous. Pooling of funds urged in health report. Journal of the American Medical
Association 1945(December 8); 129: 1037.

12.

Drew EB. The health syndicate. Atlantic Monthly December 1967; 75-82

13.

Strickland SP. Politics, science, and dread disease: A short history of United States medical
research policy..Harvard: Harvard University Press; 1972.

14.

Spingarn N. Heartbeat. Tthe politics of health research. Washington, New York: Robert B. Luce,
Inc; 1976.

15.

Shepard WP. The American Heart Association as a national voluntary public health agency,
Circulation 1950:2: 736-41.

16.

Anonymous. The American Heart Association prepares for intensified educational and fundraising activities. American Heart Journal 1947;34: 933-4.

17.

Anonymous. National heart week. American Heart Journal 1948; 35: 528.

18.

Anonymous. Gold awards given at annual dinner, American Heart Journal 1949; 38: 159.

19.

Anonymous. $ 4 million raised in heart campaign. Circulation 1950;2: 320.

20.

Anonymous. News from the American Heart Association.Circulation 1960;21: 477.

21.

Weiss S,Minot GR.. Nutrition in relation to arteriosclerosis. In: Cowdry EV, ed. Arteriosclerosis.
A survey of the problem. New York: Macmillan: 1933;233-48.

22.

Leary T. Atherosclerosis, the important form of arteriosclerosis, a metabolic disease. Journal of
the American Medical Association August 17 1935;105 (): 475-81

23.

Davis D, Stern B, Lesnick G. The lipid and cholesterol content of the blood of patients with
angina pectoris and atherosclerosis. Annals of Internal Medicine 1937; 11: 354-68

27
24.

Boas EP, Parets AD, Aldersberg D.Hereditary disturbance of cholesterol metabolism: a factor in
the genesis of atherosclerosis. American Heart Journal 1948; 35: 611-622

25.

Kempner W. Treatment of hypertensive vascular disease with rice diet. American Journal of
Medicine 1948;4: 545-77.

26.

Keys A, Mickelsen O, Miller E, Chapman CB. The relation in man between cholesterol levels in
the diet and in the blood, Science 1950;112: 79-81.

27.

Keys A, Anderson JT. The relationship of the diet to the development of atherosclerosis in man.
In: Symposium on atherosclerosis. Washington: National Academy of Sciences, National
Research Council 1954;181-97.

28.

Page IH. The Lewis A. Connor memorial lecture: Atherosclerosis. An introduction. Circulation
1954;10: 1-27.

29.

Adams W. The 100% American way to die. Better Homes and Gardens November 1947;26: 32,
224-231

30.

Keys A. Recollections of pioneers in nutrition: From starvation to cholesterol.Journal of the
American College of Nutrition 1990;9: 288-91

31.

Hunt SM, Kaufman M. Applying nutrition science to the public’s health. In Kaufman M, ed.
Nutrition in public health. A handbook for developing programs and services. Gaithersburg,
Maryland: Aspen Publishers Inc.;1990s14-41.

32.

Allen EV. Atherosclerosis. A symposium. Circulation 1952;5: 98-100

33.

Keys A. Seven countries. A multivariate analysis of death and coronary heart disease.
Cambridge, Massachusetts and London, England: Harvard University Press;1980.

28
34.

Doyle JT, Heslin AS, Hilleboe HE, Formel PF. Early diagnosis of ischemic heart disease. New
England Journal of Medicine 1959; 261: 1096-1101.

35.

Zukel WJ, Lewis RH, Enterline PE, Painter RC, Ralston LS, Fawcett RM, Meredith AP,
Peterson B. A short-term community study of the epidemiology of coronary heart disease.
American Journal of Public Health 1959;49: 1630-9.

36.

Paul O, Lepper MH, Phelan WH, Dupertuis GW, MacMillan A, McKean H, Park H., A
longitudinal study of coronary heart disease. Circulation 1963; 28: 20-31.

37.

Chapman JM, Massey FJ. The interrelationship of serum cholesterol, hypertension, body weight,
and risk of coronary disease. Results of the first ten years' follow-up in the Los Angeles Heart
Study. Journal of Chronic Diseases 1964;17: 933-49.

38.

McDonough JR, Hames CG, Stulb SC, Garrison GE., Coronary heart disease among negroes and
whites in Evans County, Georgia, Journal of Chronic Disease 1965;18: 443-68.

39.

Epstein FH, Ostrander LD, Johnson BC, Payne MW, Hayner NS, Keller JB, Francis T.,
Epidemiological studies of cardiovascular disease in a total community - Tecumsah, Michigan.
Annals of Internal Medicine 1965; 62: 1170-86.

40.

Gordon T., Kannel WB. The Framingham, Massachusetts, study, twenty years later. In: Kessler
II, Levin ML, eds. The community as an epidemiological laboratory. Baltimore: John Hopkins
Press; 1970.:123-44.

41.

Dawber TR, Meadors GF, Moore FE. Epidemiological approaches to heart disease: The
Framingham study. American Journal of Public Health 1951;41: 279-86.

42.

Dawber TR, Moore FE, Mann GV. Coronary heart disease in the Framingham study. American
Journal of Public Health 1957;47 Part 2: 4-23.

43.

Anonymous. Fat's the Villain. Newsweek 27 September 1954; 44:90-1.

29
44.

Clark B. Is this the no. 1 villain in heart disease? Readers Digest December 1955; 67 (): 130-6.

45.

Anonymous. The President: A difficult time. Newsweek 3 October 1955; 46: 19-21.

46.

King CG. A good idea. the history of the nutrition foundation. New York & Washington: The
Nutrition Foundation; 1976

47.

Berryman GH. Nutrition and nutritional diseases. In Rytand DA, Creger, WP eds. Annual
Review of Medicine 1959, Stanford California: Annual Reviews Inc: 10:127-44.

48.

Bello F., How good is Mr. Hurley's diet? Fortune December 1959: 60: 129-34, 188-96.

49.

Anonymous. Health claims by cooking oils due for censure. Printers' Ink 28 August1959); 278:
14-15.

50.

Anonymous. Fats and heart disease. Time 12 November 1956; 68: 45-6.

51.

Christakis G, Rinzler SH, Archer M, Winslow G, Jampel S, Stephenson J, Friedman G, Fein H,
Kraus A,James G. The anti-coronary club. A dietary approach to the prevention of coronary heart
disease - a seven-year report. American Journal of Public Health 1966;56: 299-314.

52.

Clark M. Fats – not proved guilty. Newsweek 20 May 1957; 49: 33-5

53.

Page IH, Stare FJ, Corcoran AC, Pollack H, Wilkinson CF. Atherosclerosis and the fat content of
the diet. Circulation 1957;16: 163-78.

54.

Anonymous. Heart report issued. New York Times 8May 1958: 74.

55.

Anonymous. Council on Foods and Nutrition. Journal of the American Medical Association
1959: 171 925-8.

56.

Anonymous. Unsaturated fats and oils claims get back hand from FDA. Oil, Paint and Drug
Reporter 1959;176: 7, 62

30
57.

Plumb RK 8 Physicians give advice on heart. New York Times 22 January 1959: 33

58.

Anonymous. Two apples a day. Time 1960: 76: 73.

59.

American Heart Association. Dietary fat and its relation to heart attack and strokes. Report by the
Central Committee for the Medical Community Program of the American Heart Association.
Circulation 1961;23: 133-6.

60.

Jolliffe N, Rinzler SH, Archer A., Anti-Coronary Club: Including discussion of effects of prudent
diet on serum cholesterol levels of middle-aged men. American Journal of Clinical Nutrition
1959;7: 451-62

61.

Pilkington TRE, Stafford JL, Hankin VS, Simmonds FM, Koerselman HB., Practical diets for
lowering serum lipids. a long-term study on out-patients with ischaemic heart disease.British
Medical Journal 2 January 1960: 23-5.

62.

Gofman JW, Jones HB, Lindgren FT, Lyon TP, Elliott HA, Strisower B. Blood lipids and human
atherosclerosis. Circulation 1950;2: 161-77.

63.

Jones HB, Gofman JW, Lingren FT, Lyon TP, Graham DM, Strisower B, Nichols AV.
Lipoproteins in atherosclerosis. American Journal of Medicine 1951;11: 358-79.

64.

Morrison LM. Diet in coronary atherosclerosis. Journal of the American Medical Association
1960; 173: 884-8.

65.

Marks, HM.. The Progress of experiment. Science and therapeutic reform in the United States,
1900-1990. Cambridge, Cambridge University Press; 1997

66.

Inter-Society Commission for Heart Disease Resources. Primary Prevention of Atherosclerotic
Diseases. Circulation 1970;42: A55 -A95.

31
67.

Baker, BB, Frantz ID, Keys A, Kinsell LD, Page IH, Stamler J, Stare FJ., The National DietHeart Study. An initial report. Journal of the American Medical Association 1963; 185: 105-6.

68.

National Diet-Heart Study Research Group.. The National Diet-Heart Study Final Report, AHA
Monograph Number 18. New York: American Heart Association; 1968

69.

National Institutes of Health.. A Report by the National Heart and Lung Institute Task Force on
Arteriosclerosis. Volume 1. Washington DC: DHEW Publication No. NIH 72-137; 1971

70.

MRFIT Research Group. Multiple Risk Factor Intervention Trial. Risk factor changes and
mortality results. Journal of the American Medical Association 1982; 248: 1465-77.

71.

Freidson, E. Professional dominance: The social structure of medical care. New York: Harper
and Row; 1970

72.

Beeuwkes, AM. Food faddism - A growing threat. Postgraduate Medicine 1960; 28: 75-81.

73.

Stein K. High-protein, low-carbohydrate diets: Do they work? Journal of the American Dietetic
Association 2000;100: 760-1.

74.

Garrety K. Actor networks, social worlds and controversy: The case of cholesterol, dietary fat
and heart disease. Social Studies of Science 1997; 27: 727-773.

75.

Garrety K. Science, policy, and controversy in the cholesterol arena. Symbolic Interaction 1998;
21: 401-424.

76.

Anonymous. Fat in the fire. Time 26 December 1960; 76: 33.

77.

AMA Council on Foods and Nutrition. The regulation of dietary fat. Journal of the American
Medical Association 1962;181: 411-29

78.

Anonymous. AMA Council warns against unsupervised dieting to lower cholesterol. Journal of
the American Medical Association 1962;182: 36.

32
79.

Darby WJ. Diet and coronary atheroma. Journal of the American Medical Association 1962; 182:
1328-9.

80.

Bart, P. Advertising: Dairy men open counterattack. New York Times 7August 1962: 36.

81.

Anonymous. Company answers AMA diet warning. New York Times 14 October 1962: 14.

82.

National Dairy Council. Physcians are asking us...what is the dairy industry doing about the
question of diet and heart disease? (Advertisement) Journal of the American Medical Association
1962;182: 22.

83.

Anonymous. Heart-Cancer Conference. Journal of the American Medical Association1961;176:
26.

84.

Wolanin TR. Presidential Advisory Commissions. Truman to Nixon. Wisconsin: University of
Wisconsin Press; 1975.

85.

Langer E US medicine: LBJ Commission on Heart Disease, Cancer and Stroke offers sweeping
recommendations. Science 1964; 146: 1662-64.

86.

AMA Staff Report. A national program to conquer heart disease, cancer and stroke. Journal of
the American Medical Association 1965;192: 299-301

87.

Hicks, N. Heart study group uses U.S. funds. New York Times 16 December 1970: 37.

88.

Cornfield J. Joint dependence of risk of coronary heart disease on serum cholesterol and systolic
blood pressure: A discriminant function analysis. Federation Proceedings 1962; 21 Supplement 2:
58-61.

89.

Dawber TR, Kannel WB, Revotskie N, Kagan A.The epidemiology of coronary heart diseaseThe Framingham enquiry. Proceedings of the Royal Society of Medicine 1962;55 : 265-71.

33
90.

Kannel WB, Dawber TR, Friedman GD, Glennon WE, McNamara PM., Risk factors in coronary
heart disease. an evaluation of several serum lipids as predictors of coronary heart disease.
Annals of Internal Medicine 1964; 61: 888-99.

91.

Anonymous. Heart group urges all to eat less fatty food. New York Times 9 June 1964: 71.

92.

AMA Council on Foods and Nutrition. Diet and the possible prevention of coronary atheroma. A
council statement. Journal of the American Medical Association 1965;194 : 1149-50

93.

AMA Council on Foods and Nutrition. 1972, Diet and Coronary Heart Disease, Journal of the
American Medical Association, 222 (December 25): 1647

94.

Nestle M. 1993, Food Lobbies, the Food Pyramid and U. S. Nutrition Policy, International
Journal of Health Services , 23: 483-96.

95.

Congressional Information Service. CIS Annual 1976. Washington DC: Government Printing
Office; 1977

96.

Zebich ML. The Politics of Nutrition: Issue Definition, Agenda-Setting, and Policy Formulation
in the United States. University of New Mexico: PhD Thesis; 1979

97.

Porter DV. Nutrition Policy Making in the United States Congress. Ohio State University: PhD
Thesis; 1980

98.

US Congress,. Senate Select Committee on Nutrition and Human Needs. Dietary Goals for the
United States. 95th Congress, 1st Session, February 1977. Washington DC: US Government
Printing Office; 1977

99.

Brody JE.FTC studies ads disavowing link of eggs to heart disease. New York Times 7 January
1974: 15.

34
100. Hausman P. Jack Sprat's Legacy: The Science and Politics of Fat and Cholesterol. New York:
Richard Marek Publishers; 1981
101. Congressional Information Service. CIS Annual 1977. Washington DC: Government Printing
Office; 1978
102. Congressional Information Service. CIS Annual 1978. Washington DC: Government Printing
Office; 1979
103. US Congress. 1977. Hearings Before the Select Committee on Nutrition and Human Needs of the
US Senate. 95th Congress, 1st Session. March 24, 1977. Response to the Dietary Goals for the
United States. Re: Meat. Washington DC: US Government Printing Office.
104. US Congress Senate Select Committee on Nutrition and Human Needs. Dietary Goals for the
United States. Second Edition. 95th Congress, 1st Session, December 1977. Washington DC: US
Government Printing Office; 1977
105. Broad WJ. Jump in funding feeds research on nutrition. Science 1979;204 : 1060-4.
106. Broad WJ. NIH deals gingerly with diet-disease link. Science 1979; 204: 1175-8.
107. Broad WJ. Surgeon General says get healthy, eat less meat. Science 1979; 205 : 1112-13.
108. US Surgeon General. Healthy People. The Surgeon General's Report on Health Promotion and
Disease Prevention. Washington DC: US Department of Health, Education and Welfare; 1979.
109. US Department of Agriculture & Department of Health & Human Services. Nutrition and your
health. Dietary guidelines for Americans reproduced in Nutrition Today March/April 1980: 15:
14-18.
110. Food and Nutrition Board of the National Academy of Sciences., Towards healthful diets
reproduced in Nutrition Today May/June 1980;15): 7-11

35
111.

King SS. Federal role is expanding as advisor on nutrition. New York Times 6 February1980:
C1, C8.

112. Schmeck, HM. Report prescribes exercise, less fat. New York Times 11 July 1966: 1, 14.
113.

Broad, WJ. Academy says curb on cholesterol not needed. Science 1980;208 : 1354-5.

114.

Seligman, D. Fear of eating. Fortune 30 June 1980: 101: 45.

115. Wade, N. Food boards fat report hits fire. Science 1980;209: 248-50.
116. Seligman, D. The food test. Fortune24March 1980; 101: 41.
117. Altman, LK. Report about cholesterol draws agreement and dissent. New York Times
28May1980: 16.
118. De Witt, K.Scientists clash on Academy’s cholesterol advice. New York Times 20 June 1980:
15.
119.

Friedland S. Heart study led to changes in life style. New York Times 10 October 1982: K4.

120. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial
results. I. Reduction in incidence of coronary heart disease. Journal of the American Medical
Association 1984:251: 351- 64.
121. Kronmal RA. Commentary on the published results of the Lipid Research Clinics Coronary
Primary Prevention Trial. Journal of the American Medical Association 1985; 253 : 2091-3
122. Anonymous. Sorry, it's true. Cholesterol really is a killer. Time 23 January 1984; 123: 32.
123.

Enloe C. Editorial: Coronary disease prevention should be individualized. Nutrition Today
March/April 1984; 19: 12-14

36
124. Rahimtoola, SH. Editorial: Cholesterol and coronary heart disease: A perspective. Journal of the
American Medical Association 1985; 253: 2094-5.
125. Olson RE. Mass intervention vs screening and selective intervention for the prevention of
coronary heart disease. Journal of the American Medical Association 1986; 255 : 2204-7.

126. Consensus Conference. Lowering blood cholesterol levels to prevent heart disease.Journal of the
American Medical Association 1985; 253: 2080-6.
127. Oliver MF.Consensus or nonsensus conferences on coronary heart disease Lancet 11 May1985:
1087-9
128. Moore TJ.. Heart failure. New York: Random House; 1989
129. Lenfant C. A new challenge for America: The National Cholesterol Education Program.
Circulation 1986;73: 855-6.
130. Mann GV. (ed). Coronary Heart Disease: The Dietary Sense and Nonsense. London: Janus; 1993
131.

Ravnskov U. The Cholesterol Myths.New Trends Publishing: Washington DC; 2000

132.

Cooper MJ, Zlotkin SH. An evidence-based approach to the development of national dietary
guidelines. Journal of the American Dietetic Association 2003; 102 Supplement 2: S28-S33.

